HemaVision® is a series of CE marked in vitro diagnostic (IVD) tests for fast and sensitive detection of chromosomal translocations associated with leukemia. The tests are fast one-day RT-PCR or 4 hours RT-qPCR screening tests, capable of analysing for up to 28 translocations and more than 145 clinical relevant translocation breakpoints in a single test.
The starting material for the HemaVision® tests is total RNA extracted from whole blood or bone marrow. The tests can be performed as a screening for 28 translocations or 7 translocations. Single translocation tests are also available.